Revenue
2023
2024
2025
2026
| 2026 | 2025 | 2024 | 2023 | |
|---|---|---|---|---|
| Revenue | $50.7M | $45.8M | $20.4M | $3.6M |
| Research & development | $2.4M | $760,000 | $0 | $0 |
| Operating expenses | $63.1M | $11.0M | $778,485 | $696,642 |
| Operating income | −$62.7M | $773,472 | $8.1M | −$344,093 |
| Operating margin | −123.68% | 1.69% | 39.72% | −9.52% |
| EBITDA | −$72.7M | $3.8M | $8.4M | −$138,087 |
| EBITDA margin | −143.49% | 8.26% | 41.16% | −3.82% |
| Net income | −$74.1M | $6.4M | $7.1M | −$482,783 |
| Net profit margin | −146.11% | 14.03% | 34.68% | −13.35% |
| Basic EPSper basic share | — | HK$25.91 | HK$28.58 | -HK$1.95 |
| Diluted EPSper diluted share | — | HK$25.91 | HK$28.58 | -HK$1.95 |
Reported shareholders
Reported holdings Number of shares
| Holder | Shares held |
|---|---|
Seto Wai Yue | 21.24M |
NATIONAL BANK OF CANADA /FI/ | 1.6K |
JPMORGAN CHASE & CO | 115 |
OSAIC HOLDINGS, INC. | 97 |
UBS Group AG | 23 |
Tower Research Capital LLC (TRC) | 19 |
Bars compare reported share counts. A matching total for this share class and reporting period is unavailable, so percentages are not shown.